tldrdailynews.com logo
Tag

Psa Test

All articles tagged with #psa test

Prostate Cancer Diagnoses Surge 3% Annually as Experts Stress Early Screening
health1 month ago

Prostate Cancer Diagnoses Surge 3% Annually as Experts Stress Early Screening

The American Cancer Society (ACS) projects 333,830 new prostate cancer cases in 2026, noting a 3% annual rise in diagnoses from 2014 to 2022. While increased screening drives higher detection rates, experts warn that many cases are now identified at advanced stages. Urologists emphasize that early detection offers a nearly 100% five-year survival rate for localized disease, urging men to begin screening conversations earlier, particularly those with high-risk factors.

via Healthline|
#american-cancer-society#early-detection#health
Prostate Cancer Awareness Month: Debunking Myths and Emphasizing Early Screening
health1 month ago

Prostate Cancer Awareness Month: Debunking Myths and Emphasizing Early Screening

As Prostate Cancer Awareness Month begins, experts and media outlets are urging men to prioritize early screening over waiting for symptoms. Recent data indicates that early-stage prostate cancer often presents without warning signs, making proactive PSA testing critical. While the disease affects approximately 1 in 8 men, survival rates remain high if detected before metastasis. Medical professionals are also highlighting the shift toward active surveillance for low-risk cases to reduce overtreatment, alongside new non-invasive diagnostic methods.

via NDTV|
#active-surveillance#health#prostate-cancer
Why Routine PSA Screening Remains Controversial Despite High Prostate Cancer Rates
health1 month ago

Why Routine PSA Screening Remains Controversial Despite High Prostate Cancer Rates

Prostate cancer is the most common invasive cancer in men, with 330,000 new cases expected in 2026, yet doctors do not automatically order PSA blood tests for all patients. The test detects prostate-specific antigen levels, which can indicate cancer, but its use is debated due to the slow-growing nature of the disease and the potential for overdiagnosis. While early detection offers curative options like surgery or radiation, the lack of universal screening reflects ongoing medical uncertainty about the benefits versus harms of routine testing.

via The Washington Post|
#cancer-detection#health#mens-health
New PSA screening data hint at mortality benefit, but gains remain modest
health5 months ago

New PSA screening data hint at mortality benefit, but gains remain modest

A updated Cochrane review, incorporating data from nearly 800,000 people and longer follow-up, suggests PSA-based prostate cancer screening likely reduces mortality and does not notably increase biopsy or treatment harms, reversing previous Cochrane findings from 2006 and 2013. The absolute benefit is small, and guidelines worldwide remain mixed due to concerns about overdiagnosis and overtreatment.

via Nature|
#cancer-screening#cochrane-review#health
PSA screening cuts prostate cancer deaths but benefits are modest and risks exist
health5 months ago

PSA screening cuts prostate cancer deaths but benefits are modest and risks exist

A large Cochrane review of six PSA screening trials (nearly 800,000 men) finds PSA testing can reduce prostate cancer deaths, but the absolute benefit is small (about 2 lives saved per 1,000 screened; 500 men need screening to prevent one death). Benefits emerge only with long follow-up, while many men face overdiagnosis and potential harms from treatment, such as incontinence or erectile dysfunction. The authors caution against universal screening and emphasize shared decision making, with targeted approaches for high-risk groups and ongoing development of MRI- and biomarker–based methods whose extra benefit remains uncertain.

via The Guardian|
#health#overdiagnosis#prostate-cancer
Overdiagnosis Rises Sharply After 70 in PSA Prostate Screening, Study Finds
health5 months ago

Overdiagnosis Rises Sharply After 70 in PSA Prostate Screening, Study Finds

A UK analysis of over 400,000 men finds PSA-based prostate cancer screening has low overdiagnosis risk in men in their 50s–60s but rises sharply after 70 due to higher competing mortality; 16% of PSA-detected cancers would not become clinically relevant within 15 years at age 50, rising to 32% at 70 and 58% at 80. Consequently, screening offers little net benefit for men over 70, though MRI-guided biopsy and ongoing trials may reduce harms from overdiagnosis; decisions should be individualized, especially for older men.

via The Conversation|
#aging#health#overdiagnosis
Living with Prostate Cancer: PSA testing, treatment hurdles, and a UK screening debate
health7 months ago

Living with Prostate Cancer: PSA testing, treatment hurdles, and a UK screening debate

UK men face rising prostate cancer diagnoses while a National Screening Committee says broad PSA screening isn’t justified due to risks of overdiagnosis and overtreatment, even as awareness grows and access varies by socioeconomic status. The piece follows men like Bulteel, Pennington, Walsh and Hemans, illustrating how PSA testing can detect cancer early but also lead to difficult treatment paths (surgery, radiotherapy, hormone therapy) and significant emotional and relational strain, highlighting disparities in access and the push for targeted screening for at‑risk groups.

via The Guardian|
#health#health-inequality#hormone-therapy
Three Bathroom Clues That Could Signal Hidden Prostate Cancer
health7 months ago

Three Bathroom Clues That Could Signal Hidden Prostate Cancer

Prostate cancer often develops without noticeable early signs, but three bathroom-related warning signs—more frequent urination, straining to urinate, and a feeling of incomplete bladder emptying—along with other symptoms like weak urine flow or nocturia, highlight the importance of talking with a doctor about PSA screening for earlier detection and potentially better outcomes.

via Indian Defence Review|
#cancer-awareness#early-detection#health
health9 months ago

Croatia rolls out nationwide PSA screening as the UK weighs its approach

Croatia has announced a national prostate cancer screening programme offering annual PSA tests for men aged 55–69, set to begin next year, as the UK debates its own stance after the UK National Screening Committee’s cautious recommendation; early data show Croatia’s five-year survival is higher than Britain's, with several other countries piloting or planning routine PSA screenings.

via The Telegraph|
#croatia#health#prostate-cancer
Debate Over Prostate Cancer Testing Methods and Efficacy
health1 year ago

Debate Over Prostate Cancer Testing Methods and Efficacy

The article discusses the pros and cons of PSA testing for prostate cancer, emphasizing that while it can produce false positives leading to unnecessary procedures, careful testing and risk assessment can help identify high-risk cases and save lives. The author supports PSA screening for men aged 50-70 and suggests that digital rectal exams add little value and often result in false positives, but individual discussions with doctors are important.

via OregonLive.com|
#dre#false-positives#health